abstract
-
Simeprevir is a new direct-acting antiviral drug used for the treatment of chronic hepatitis C.
Identification, isolation, structural characterization, in silico toxicity prediction and in vitro cytotoxicity assay of simeprevir acidic and oxidative degradation products
Academic Article
- Overview
- Identity
- Additional document info
- View All
Overview
authors
publication date
- 2020
published in
- RSC Advances Journal
is a research-focused discovery tool that enables collaboration among scientists across all disciplines.
Browse or search information on people, departments, courses, grants, and publications.